Aflibercept for Diabetic Macular Edema in Real-Life Practice in GREece: Three-Year Outcomes of the ADMIRE Study
CONCLUSION: Intravitreal aflibercept was found to be safe and effective for the treatment of DME in real-life in a Greek population. Treatment-naive patients and those who received a loading dose of five consecutive monthly injections at initiation of treatment exhibited better outcomes, suggesting that early and effective treatment may prevent vision loss.PMID:37539994 | DOI:10.1080/08820538.2023.2243308
Source: Seminars in Ophthalmology - Category: Opthalmology Authors: Irini Chatziralli Chrysa Agapitou Eleni Dimitriou Petros Kapsis Dimitrios Kazantzis Genovefa Machairoudia Odysseas Georgiadis George Theodossiadis Panagiotis Theodossiadis Source Type: research
More News: Diabetes | Endocrinology | Eyes | Greece Health | Lucentis | Opthalmology | Ranibizumab Injection | Study